Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, October 01, 2014
Register | Sign in
Home Page>News

  News Archive

NIH Exceptional Responders to Cancer Therapy Study Launched
Friday, September 26, 2014
Study to investigate the molecular factors of tumors associated with exceptional treatment responses of cancer patients to drug therapies.

NIH Announces Network to Accelerate Medicines for Rheumatoid Arthritis and Lupus
Friday, September 26, 2014
Partnership includes support from industry and non-profits.

Monkey Antibodies Help Fight Virus
Friday, September 26, 2014
Details of monkey antibodies against chikungunya virus could help to fight the disease in humans.

Protecting the Body from Itself
Friday, September 26, 2014
Scientists advance understanding of autoimmunity with discovery of link between major immune cell types.

Catalent and Cingulate Therapeutics Sign Exclusive Agreement
Friday, September 26, 2014
Licensing agreement for development of new ADHD treatments.

Bio Innovation Hub to Open in Liverpool
Friday, September 26, 2014
The hub will allow commercial access to the latest biobank technologies and equipment in the study of areas such as genomics, proteomics and metabolomics.

Emergent BioSolutions Initiates Final Pivotal Study to Support Licensure of BioThrax
Friday, September 26, 2014
Large scale manufacturing of BioThrax in Building 55 will increase annual production capacity from 7-9 million doses to a target of 20-25 million doses.

FDA Food Safety Challenge
Friday, September 26, 2014
Challenge aims to spur new technologies for fighting foodborne illness.

Avalon Ventures and GlaxoSmithKline Launch Two New Companies
Friday, September 26, 2014
Companies include Silarus Therapeutics developing treatments for anemia and iron overload disorders; and Thyritope Biosciences developing treatments for Graves’ orbitopathy.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 26666
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to